Bio-Rad Buys Bigger Stake in BioSource After Firm Rejected Earlier Acquisition Offer | GenomeWeb

NEW YORK, April 19 (GenomeWeb News) - After BioSource International rebuffed Bio-Rad's recent unsolicited $82 million acquisition offer, Bio-Rad today said it has increased its ownership in the reagents company to 6.8 percent from 5 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.